Tocagen, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.24%59.150.0%$1901.50m
REGNRegeneron Pharmaceuticals, Inc. 0.92%609.852.5%$1237.05m
GILDGilead Sciences, Inc. 0.65%74.881.0%$958.60m
NVAXNovavax, Inc. 4.00%46.02102.0%$633.44m
AMGNAmgen, Inc. 0.80%222.761.3%$629.83m
VRTXVertex Pharmaceuticals, Inc. 0.63%278.741.9%$557.13m
ILMNIllumina, Inc. 0.92%361.603.5%$381.76m
BIIBBiogen, Inc. 0.24%303.311.6%$377.60m
ALXNAlexion Pharmaceuticals, Inc. -0.33%113.402.0%$277.20m
SRNESorrento Therapeutics, Inc. -4.23%3.971.8%$251.40m
SGENSeattle Genetics, Inc. 0.37%155.626.1%$242.06m
AAgilent Technologies, Inc. 0.30%90.761.6%$210.90m
BMRNBioMarin Pharmaceutical, Inc. 0.57%111.854.3%$192.55m
MGNXMacroGenics, Inc. 1.24%21.276.2%$168.28m
INCYIncyte Corp. 0.10%98.932.5%$163.71m

Company Profile

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.